- Home
- ALXO vs STAK Comparison
ALXO vs STAK Comparison
Compare ALXO & STAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- STAK
- Stock Information
- Founded
- ALXO 2015
- STAK 2020
- Country
- ALXO United States
- STAK China
- Employees
- ALXO N/A
- STAK N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- STAK
- Sector
- ALXO Health Care
- STAK
- Exchange
- ALXO Nasdaq
- STAK NYSE
- Market Cap
- ALXO 24.0M
- STAK 20.9M
- IPO Year
- ALXO 2020
- STAK 2025
- Fundamental
- Price
- ALXO $0.48
- STAK $2.05
- Analyst Decision
- ALXO Strong Buy
- STAK
- Analyst Count
- ALXO 6
- STAK 0
- Target Price
- ALXO $3.30
- STAK N/A
- AVG Volume (30 Days)
- ALXO 397.6K
- STAK 1.5M
- Earning Date
- ALXO 08-07-2025
- STAK 01-01-0001
- Dividend Yield
- ALXO N/A
- STAK N/A
- EPS Growth
- ALXO N/A
- STAK 6.02
- EPS
- ALXO N/A
- STAK 0.28
- Revenue
- ALXO N/A
- STAK $22,248,609.00
- Revenue This Year
- ALXO N/A
- STAK N/A
- Revenue Next Year
- ALXO N/A
- STAK N/A
- P/E Ratio
- ALXO N/A
- STAK $7.25
- Revenue Growth
- ALXO N/A
- STAK N/A
- 52 Week Low
- ALXO $0.41
- STAK $1.13
- 52 Week High
- ALXO $8.78
- STAK $4.53
- Technical
- Relative Strength Index (RSI)
- ALXO 44.63
- STAK N/A
- Support Level
- ALXO $0.48
- STAK N/A
- Resistance Level
- ALXO $0.59
- STAK N/A
- Average True Range (ATR)
- ALXO 0.05
- STAK 0.00
- MACD
- ALXO -0.00
- STAK 0.00
- Stochastic Oscillator
- ALXO 8.75
- STAK 0.00
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About STAK STAK INC.
Stak Inc is engaged in research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment. It design and manufacture oilfield-specialized production and maintenance equipment and also sell oilfield-specialized production and maintenance equipment components, related products, and provide automation solutions. Its products include oilfield vehicles such as oil pumping trucks, oil-well repair trucks, fracking trucks, well flushing-wax removal trucks, and boiler trucks. The company also produce specialized equipment and components for oil well repair and maintenance, fracking, oil well cleaning and wax removal, oil pumping, and boilers.